| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/27/2014 | US20140056813 Nanoparticles delivery systems, preparation and uses thereof |
| 02/27/2014 | US20140056812 Imaging Beta Cell Mass |
| 02/27/2014 | US20140056809 Treatment and diagnosis of macrophage mediated disease |
| 02/27/2014 | US20140056808 Neoantibodies for diagnosing tissue injury |
| 02/26/2014 | EP2699620A1 Cross-linked poly-e-lysine non-particulate support |
| 02/26/2014 | EP2699619A1 Cross-linked poly-e-lysine particles |
| 02/26/2014 | EP2699556A1 Preparation of high-purity gadobutrol |
| 02/26/2014 | EP2699272A1 Targeted contrast agents and uses thereof |
| 02/26/2014 | CN103608337A <18>F-marked precursor of PET radioactive medical supplies, and preparation method thereof |
| 02/26/2014 | CN103599068A Drug-loaded nano-micelle, anti-cancer medicament and preparation method thereof |
| 02/26/2014 | CN101518528B Application of carbocyanine dye near infrared fluorescent compound |
| 02/25/2014 | US8658215 Injectable microspheres for dermal augmentation and tissue bulking |
| 02/25/2014 | US8658205 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 02/25/2014 | US8658136 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
| 02/25/2014 | US8658133 Methods and compositions relating to alzheimer's disease |
| 02/25/2014 | US8658129 Agents and methods for the imaging of myelin basic protein |
| 02/25/2014 | CA2629227C Precursor compound of radioactive halogen-labeled organic compound |
| 02/20/2014 | WO2014028057A1 Prostate specific antigen agents and methods of using same for prostate cancer imaging |
| 02/20/2014 | WO2014027203A1 Inflammation imaging and therapy |
| 02/20/2014 | WO2014026283A1 Peptide-dendrimer conjugates and uses thereof |
| 02/20/2014 | WO2013108044A8 Norbornene modified peptides and their labelling with tetrazine compounds |
| 02/20/2014 | US20140053288 Epo knockout gfp anemic mouse |
| 02/20/2014 | US20140051996 Subcutaneous cavity marking device and method |
| 02/20/2014 | US20140051863 Fluorescent probes for detection of copper |
| 02/20/2014 | US20140050671 Theranostic nanoparticle and methods for making and using the nanoparticle |
| 02/20/2014 | US20140050670 Multifunctional nanoparticles |
| 02/20/2014 | US20140050669 Use of radiographic contrast agents for detecting dental caries |
| 02/20/2014 | US20140050668 Visualization of lipid metabolism |
| 02/20/2014 | US20140050667 Renal function analysis method and apparatus |
| 02/20/2014 | US20140050666 Scavenger receptor uptake for fabry disease enzyme replacement therapy |
| 02/20/2014 | US20140050665 Method for the treatment or prophylaxis of lymphangioleiomyomatosis (lam) and animal model for use in lam research |
| 02/20/2014 | US20140050662 Prostate specific antigen agents and methods of using same for prostate cancer imaging |
| 02/20/2014 | US20140050386 Systems and methods for in vitro and in vivo imaging of cells on a substrate |
| 02/19/2014 | EP2698170A1 Use of DTBZ for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 02/19/2014 | EP2698169A1 A contrast agent-binding polypeptide and use thereof |
| 02/19/2014 | EP2696900A2 Dyes for membranes and biological structures |
| 02/19/2014 | CN103597039A Activatable fluorogenic compounds and uses thereof as near infrared probes |
| 02/19/2014 | CN103597011A Cross-linked poly-E-lysine particles |
| 02/19/2014 | CN103596605A Device with echogenic coating |
| 02/19/2014 | CN103596604A Echo reflection enhanced device |
| 02/19/2014 | CN103588880A Compositions and methods for regulating NK cell activity |
| 02/19/2014 | CN103585645A Three-dimensional (3D)-printing-based biocompatible ultrasonic contrast agent and preparation method thereof |
| 02/19/2014 | CN103585644A Polyethylene glycol modified magnetic nanoparticle and application thereof |
| 02/19/2014 | CN103585619A Application of DJ-1 protein in preparation of product for diagnosis and therapy of osteosarcoma |
| 02/19/2014 | CN103585105A Sphingolipid activator protein C for transmembrane medicine delivering system as well as associated protein and peptide-promoted fusion protein |
| 02/19/2014 | CN102793931B CT contrast media for specific targeting tumor neovascularization and preparation method thereof |
| 02/19/2014 | CN102125695B Polyglutamate-amino acid conjugates and methods |
| 02/19/2014 | CN101696977B Method for determining stage of neurofibrillary degeneration |
| 02/18/2014 | US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/14/2014 | CA2786368A1 Method and apparatus for diagnosis of tumor activity using tumor interstitial fluid pressure |
| 02/13/2014 | WO2014026044A2 Extrusion methods and devices for drug delivery |
| 02/13/2014 | WO2014025892A1 Predicting bladder cancer responsiveness to bcg |
| 02/13/2014 | WO2014023178A1 Obesity animal model and methods for making and using thereof |
| 02/13/2014 | WO2013009475A8 Photosensitizing antibody-fluorophore conjugates |
| 02/13/2014 | US20140047570 Animal model of human cancer and methods of use |
| 02/13/2014 | US20140047569 Methods of Treating Disorders Associated with Protein Aggregation |
| 02/13/2014 | US20140046361 Bioabsorbable co-filler for cerebrovascular aneurysms |
| 02/13/2014 | US20140044737 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 02/13/2014 | US20140044648 Activatable imaging contrast agents |
| 02/13/2014 | US20140044646 Labeled, Non-Peptidic, Multivalent Integrin Antagonist Compounds; Methods for Synthesis and Uses Thereof |
| 02/13/2014 | US20140044644 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 02/13/2014 | US20140044643 Magnetic Calcium Phosphate Nanoparticles, Applications And Methods Of Preparation Thereof |
| 02/12/2014 | EP2694117A1 Polymalic acid based nanoconjugates for imaging |
| 02/12/2014 | EP2694116A2 Lipid-based nanoparticles |
| 02/12/2014 | EP2694115A2 Optical imaging probes |
| 02/12/2014 | CN103582651A Monoclonal antibody capable of recognizing human papilloma virus (HPV) L2 protein, and method for measuring HPV-neutralizing antibody titer using same |
| 02/12/2014 | CN103582643A 蛋白激酶抑制剂 Protein kinase inhibitors |
| 02/12/2014 | CN103582500A Bismuth particle X-ray contrast agents |
| 02/12/2014 | CN103582497A Polymalic acid based nanoconjugates for imaging |
| 02/12/2014 | CN103582494A Compositions targeting the soluble extracellular domain of E-cadherin and related methods for cancer therapy |
| 02/12/2014 | CN103582492A Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
| 02/12/2014 | CN103571874A Application of BIGH3 in preparation of animal model with corneal dystrophy |
| 02/12/2014 | CN103571458A Selenium-containing fluorine-boron dye fluorescent probe and application thereof in ClO<-> detection |
| 02/12/2014 | CN103571456A Fluorescence probe for detecting nitrosyl peroxide by utilizing amido bond rupture and application of fluorescence probe |
| 02/12/2014 | CN103566381A Multifunctional magnetic nano particle and preparation method thereof |
| 02/12/2014 | CN103566380A Preparation method of bifunctional contrast agent based on up-conversion material and gadolinium chelate |
| 02/12/2014 | CN103566354A Pharmaceutical composition containing derivatives of GLP-1 analogue or medicinal salts thereof |
| 02/12/2014 | CN103565744A Macromolecular phosphatidylglycerol nanoliposome, and preparation methods and applications thereof |
| 02/12/2014 | CN102643225B Ionic liquid, nano fluorescent ellipsoid and preparation method thereof |
| 02/11/2014 | US8647825 Compositions and methods relating to monitoring alcohol consumption and alcohol abuse |
| 02/11/2014 | US8647630 Mite allergen |
| 02/11/2014 | CA2531894C Inherently radiopaque polymeric products for embolotherapy |
| 02/11/2014 | CA2529496C Anti-cd74 immunoconjugates and methods |
| 02/06/2014 | WO2014021630A1 Aptamer specific to integrin αvβ3 and use thereof |
| 02/06/2014 | WO2014020933A1 Novel fluorescent substance |
| 02/06/2014 | WO2014020285A1 Fluorogenic glycosidase substrate and associated detection method |
| 02/06/2014 | WO2014020264A1 Novel iron complexes capable of detecting a nitro-reducing chemical or biochemical entity, in particular by in vivo mri, and in vitro detection method |
| 02/06/2014 | WO2014019025A1 Epcam aptamer for detection of cancer stem cells |
| 02/06/2014 | WO2013188755A3 Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo |
| 02/06/2014 | US20140041065 Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same |
| 02/06/2014 | US20140041063 Genetically Modified Rat Models for Obesity and Diabetes |
| 02/06/2014 | US20140038856 Site-specific labeling of affinity tags in fusion proteins |
| 02/06/2014 | US20140037554 Cupredoxin derived transport agents and methods of use thereof |
| 02/06/2014 | US20140037553 Bacterium-based microrobot capable of targeting cancer tissue |
| 02/06/2014 | US20140037552 Prussian blue based nanoparticle as multimodal imaging contrast material |
| 02/06/2014 | US20140037548 Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors |
| 02/06/2014 | US20140037546 Mixture of liquid-crystal compounds, system of three liquid-crystal mixtures and their use |
| 02/06/2014 | US20140037545 Inhibition of fibrosis and af by tgf-beta inhibition in the posterior left atrium (pla) |
| 02/06/2014 | US20140037542 Novel theranostic platform for targeted cancer therapy and drug delivery monitoring |